Actively Recruiting

Age: 1Day - 18Years
All Genders
ID04664569

National Observatory of Bacterial Meningitis in Children and Newborns

Led by Association Clinique Thérapeutique Infantile du val de Marne · Updated on 2026-04-28

10000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

A

Association Clinique Thérapeutique Infantile du val de Marne

Lead Sponsor

P

Pfizer

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting a national observational study to understand bacterial meningitis in children and newborns. This study focuses on the bacteria that cause meningitis, how vaccination has influenced its occurrence, and the treatment outcomes in children under 18 who are hospitalized with this condition. The goal is to describe the changing epidemiology of bacterial meningitis, especially in the context of vaccine use. The study collects detailed data on hospitalized children including risk factors, vaccination status, symptoms, and treatments given during hospital stays. Laboratory analyses such as cerebrospinal fluid cultures, antigen tests, blood cultures, and PCR are used to identify the bacteria involved. The study also tracks cases of purpura fulminans, a serious complication related to bacterial infections. Participants will be monitored during their hospital stay with focus on mortality before discharge, treatment failures 48 hours after antibiotics and repeat lumbar puncture, and the impact of vaccines. Data on clinical signs and laboratory results are collected to support the study. The study began in 2001 and continues to gather information to improve understanding of bacterial meningitis in this population.

CONDITIONS

Brief Title

National Bacterial Meningitis Study in Children and Newborns

Who Can Participate

Age: 1Day - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical signs of meningitis with positive cerebrospinal fluid culture and/or antigen test for specific bacteria, and/or positive cerebrospinal fluid PCR, and/or positive blood culture with cerebrospinal fluid pleocytosis (> 10 cells/µL)
  • Presence of purpura fulminans
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Duration of hospitalization

Participants who undergo routine hospital care for bacterial meningitis are observed. Data on risk factors, vaccination status, signs and symptoms, and treatment during hospitalization are collected.

Visits as part of routine hospital care

Trial Site Locations

Total: 1 location

1

ACTIV

Créteil, France

Actively Recruiting

Loading map...

Research Team

C

Corinne Levy, MD

S

Stephane Bechet

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Prospective Clinical Registry of Acute Treatment and Long-te...

Viral Meningitis

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Retrospective Description of 27 Cases of Nontyphoidal Salmonella Meningitis in Pediatrics Over 22 Years in France Pleads for a Revision of Age Limit for the Treatment of Salmonella Gastroenteritis in Children.

Louise Maunier, Corinne Levy, Audrey Baron...

https://pubmed.ncbi.nlm.nih.gov/40924727

High Mortality Due to Pneumococcal Meningitis in Children With Sickle Cell Disease: A French Multicenter Observational Study From 2001 to 2021.

Inès Fafi, Robert Cohen, Corinne Levy...

https://pubmed.ncbi.nlm.nih.gov/40063777

Vaccine-preventable Pediatric Acute Bacterial Meningitis in France: A Time Series Analysis of a 19-Year Prospective National Surveillance Network.

Alexis Rybak, Naïm Ouldali, Emmanuelle Varon...

https://pubmed.ncbi.nlm.nih.gov/38108805